X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Novartis with Piramal Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs PIRAMAL ENTERPRISES - Comparison Results

NOVARTIS    Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS PIRAMAL ENTERPRISES NOVARTIS/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 433.3 26.4 1,643.6% View Chart
P/BV x 30.6 1.2 2,505.6% View Chart
Dividend Yield % 1.5 1.3 111.9%  

Financials

 NOVARTIS   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    NOVARTIS
Mar-18
PIRAMAL ENTERPRISES
Mar-18
NOVARTIS/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs7583,083 24.6%   
Low Rs5791,902 30.4%   
Sales per share (Unadj.) Rs228.4589.7 38.7%  
Earnings per share (Unadj.) Rs31.7284.0 11.2%  
Cash flow per share (Unadj.) Rs32.8310.5 10.6%  
Dividends per share (Unadj.) Rs10.0025.00 40.0%  
Dividend yield (eoy) %1.51.0 149.1%  
Book value per share (Unadj.) Rs297.11,467.0 20.3%  
Shares outstanding (eoy) m24.69180.27 13.7%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x2.94.2 69.3%   
Avg P/E ratio x21.18.8 240.0%  
P/CF ratio (eoy) x20.48.0 254.2%  
Price / Book Value ratio x2.21.7 132.4%  
Dividend payout %31.58.8 358.0%   
Avg Mkt Cap Rs m16,505449,332 3.7%   
No. of employees `0000.76.8 9.8%   
Total wages/salary Rs m1,44519,881 7.3%   
Avg. sales/employee Rs Th8,441.315,535.6 54.3%   
Avg. wages/employee Rs Th2,163.62,905.4 74.5%   
Avg. net profit/employee Rs Th1,173.17,482.5 15.7%   
INCOME DATA
Net Sales Rs m5,639106,310 5.3%  
Other income Rs m1,7182,595 66.2%   
Total revenues Rs m7,357108,906 6.8%   
Gross profit Rs m-6351,599 -0.1%  
Depreciation Rs m254,773 0.5%   
Interest Rs m5529,783 0.2%   
Profit before tax Rs m1,57519,638 8.0%   
Minority Interest Rs m02,801 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m792-28,764 -2.8%   
Profit after tax Rs m78451,203 1.5%  
Gross profit margin %-1.148.5 -2.3%  
Effective tax rate %50.3-146.5 -34.3%   
Net profit margin %13.948.2 28.9%  
BALANCE SHEET DATA
Current assets Rs m9,522118,154 8.1%   
Current liabilities Rs m3,296462,260 0.7%   
Net working cap to sales %110.4-323.7 -34.1%  
Current ratio x2.90.3 1,130.2%  
Inventory Days Days3727 137.8%  
Debtors Days Days2847 61.1%  
Net fixed assets Rs m46113,727 0.0%   
Share capital Rs m123361 34.2%   
"Free" reserves Rs m7,213264,093 2.7%   
Net worth Rs m7,336264,454 2.8%   
Long term debt Rs m0242,206 0.0%   
Total assets Rs m11,105726,834 1.5%  
Interest coverage x29.51.7 1,776.9%   
Debt to equity ratio x00.9 0.0%  
Sales to assets ratio x0.50.1 347.2%   
Return on assets %7.611.1 67.8%  
Return on equity %10.719.4 55.2%  
Return on capital %22.210.3 215.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6115,110 0.4%   
Fx outflow Rs m3,6304,298 84.5%   
Net fx Rs m-3,57010,813 -33.0%   
CASH FLOW
From Operations Rs m1,610-159,666 -1.0%  
From Investments Rs m687-17,677 -3.9%  
From Financial Activity Rs m-2,677186,503 -1.4%  
Net Cashflow Rs m-3809,364 -4.1%  

Share Holding

Indian Promoters % 0.0 52.9 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 2.0 4.0 50.0%  
FIIs % 1.6 26.6 6.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 16.5 130.3%  
Shareholders   41,647 93,274 44.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   DISHMAN PHARMA  ELDER PHARMA  ALEMBIC LTD  PANACEA BIOTECH  CADILA HEALTHCARE  

Compare NOVARTIS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End on a Positive Note; Oil & Gas and IT Stocks Witness Buying(Closing)

Indian share markets traded on a positive note most of the day and ended marginally higher. Gains were seen in the oil & gas sector and IT sector.

Related Views on News

KAVERI SEED Plunges by 5%; BSE 500 Index Down 0.2% (Market Updates)

Jun 18, 2019 | Updated on Jun 18, 2019

KAVERI SEED share price has plunged by 5% and its current market price is Rs 474. The BSE 500 is down by 0.2%. The top gainers in the BSE 500 Index are SRF LTD (up 4.0%) and SHREE CEMENT (up 3.3%). The top losers are KAVERI SEED (down 5.0%) and PIRAMAL ENTERPRISES (down 6.4%).

SREI INFRA FINANCE Plunges by 5%; BSE 500 Index Up 0.1% (Market Updates)

Jun 18, 2019 | Updated on Jun 18, 2019

SREI INFRA FINANCE share price has plunged by 5% and its current market price is Rs 21. The BSE 500 is up by 0.1%. The top gainers in the BSE 500 Index are SRF LTD (up 4.6%) and ASAHI INDIA (up 4.1%). The top losers are SREI INFRA FINANCE (down 5.1%) and PIRAMAL ENTERPRISES (down 5.7%).

GRANULES INDIA Plunges by 5%; BSE HEALTHCARE Index Down 0.2% (Market Updates)

Jun 18, 2019 | Updated on Jun 18, 2019

GRANULES INDIA share price has plunged by 5% and its current market price is Rs 96. The BSE HEALTHCARE is down by 0.2%. The top gainers in the BSE HEALTHCARE Index are ASTRAZENECA PHARMA (up 3.4%) and JUBILANT LIFE SCIENCES (up 3.1%). The top losers are GRANULES INDIA (down 5.4%) and PIRAMAL ENTERPRISES (down 5.8%).

NOVARTIS Announces Quarterly Results (4QFY19); Net Profit Down 26.2% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, NOVARTIS has posted a net profit of Rs 195 m (down 26.2% YoY). Sales on the other hand came in at Rs 1 bn (down 11.9% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (4QFY19); Net Profit Down 91.4% (Quarterly Result Update)

Apr 30, 2019 | Updated on Apr 30, 2019

For the quarter ended March 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 3 bn (down 91.4% YoY). Sales on the other hand came in at Rs 37 bn (up 23.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

Just One Stock Made Buffett Billions - And Can Make You Crores(Profit Hunter)

Jun 6, 2019

Coca Cola is arguably one of Warren Buffet's best stock picks. But did you know that small investors picked up the stock five decades before Buffet? Read on...

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why Modi 2.0 Will Be Great for These 7 Stocks(Profit Hunter)

Jun 10, 2019

The government's focus on Infra, electricity, water for all will be the key factors for Sensex 1,00,000.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Jun 18, 2019 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS 8-QTR ANALYSIS

COMPARE NOVARTIS WITH

MARKET STATS